PHXM
NASDAQ
$3.10
PHAXIAM Therapeutics SA ADR (PHXM)
PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. The company is headquartered in Lyon, France.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$20M
Price Chart
Valuation
Market Cap$20M
Profitability
EBITDA-$19M
Profit Margin-191%
Operating Margin-3232%
EPS-$13.61
Financial Health
Debt-to-Equity42.6%
Growth & Risk
Sharpe Ratio2.53